EMIS Prepares for MedifyRemote Roll Out

Toronto, Canada, November 2 (ots/PRNewswire) - EMIS, the UK's
leading provider of IT systems to the primary care market is
preparing to make the MedifyRemote product available across its UK
customer base.

Approximately 55% of all doctors in the UK currently use EMIS
software each day.

EMIS has been instrumental, through the NHS pilots, making sure
the product not only meets customers needs but also the pre-requisite
national standards of security required for a national solution.
MedifyRemote, delivered as part of the EMIS Partner Programme, will
lead the way in real time mobile secure access for fully functional
remote patient record access.

EMIS is a keen supporter of leading edge technologies that can
improve the provision of healthcare, benefiting clinicians and
patients alike.

MedifyRemote delivers the highest approved level of security for
remote access to patient notes anywhere anytime and due to the
functionality of MedifyRemote, Doctors can access and view patient
notes and historical information, to ensure continuity of care and
clinical accuracy. In a single secure transaction, the patient visit
and any actions are recorded directly through the MedifyRemote
product and updated real-time into the patient's medical record held
at the doctor's surgery.

MedifyRemote will be available through Medify's approved, secure
mobile connection to the NHS National Spine (N3) for viewing and
updating patient records.

The MedifyRemote product will be available on a Microsoft platform
and Blackberry devices alike.

Darryl Cox, EMIS Project director, said: "Working on this project
in partnership with Medify has been exciting and rewarding,
delivering a project that creates a leading edge solution". GPs are
increasingly mobile and it's vital that they have secure, safe and
easy access to their patients' medical records on the go.

Ian O 'Reilly, CEO Medify Solutions, commented: "We all believed
in the product and the project, to be in a position with EMIS to have
reached this point is real justification. Working closely with EMIS
to not only take to market a product which we believe gives customer
satisfaction, but through the recent EMIS National User Group
conference feedback, we now know the product is in demand by
Healthcare purchasers. To ensure the MedifyRemote proposition is made
commercially available through EMIS's leading UK position, is the
commercial realisation of the Medify business plan.

Medify Solutions Ltd - Pink Sheets MDFY

www.medifysolutions.com

This news release contains forward-looking statements that are
subject to certain risks and uncertainties that may cause actual
results to differ materially from those projected on the basis of
such forward-looking statements. The words "estimate," "project,"
"intends," "expects," "believes," and similar expressions are
intended to identify forward-looking statements. Such forward-looking
statements are made based on management's beliefs, as well as
assumptions made by, and information currently available to,
management pursuant to the "safe-harbour" provisions of the Private
Securities Litigation Reform Act of 1995. For a more complete
description of these and other risk factors that may affect the
future performance of Medify Solutions Limited, see "Risk Factors" in
the Company's Annual Report on Form 10-KSB and its other filings with
the Securities and Exchange Commission. Readers are cautioned not to
place undue reliance on these forward-looking statements, which speak
only as of the date made and the Company undertakes no obligation to
disclose any revision to these forward-looking statements to reflect
events or circumstances after the date made or to reflect the
occurrence of unanticipated events.

ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.de

Contact:
For further information: Chris Hill - enquiries@medifysolutions.com